758 results on '"Skowasch, Dirk"'
Search Results
2. Assessing sleep-related breathing disorders among newly diagnosed rheumatoid and psoriatic arthritis patients: a cross-sectional study
3. Disease trajectories in interstitial lung diseases – data from the EXCITING-ILD registry
4. Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry
5. Autorinnen und Autoren
6. Relevance of serum levels of the endoplasmic reticulum stress protein GRP78 (glucose-regulated protein 78 kDa) as biomarker in pulmonary diseases
7. Real-World Data on Tezepelumab in Patients With Severe Asthma in Germany
8. Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era
9. Dupilumab bei chronisch-obstruktiver Lungenerkrankung
10. Cardiac autonomic dysfunction in adult congenital heart disease
11. Relevance of serum levels of the endoplasmic reticulum stress protein GRP78 (glucose-regulated protein 78 kDa) as biomarker in pulmonary diseases
12. Prevalence of sleep-disordered breathing in patients with mitral regurgitation and the effect of mitral valve repair
13. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
14. ER-stress-induced secretion of circulating glucose-regulated protein 78kDa (GRP78) ameliorates pulmonary artery smooth muscle cell remodelling
15. Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists
16. Characterization of Obesity in Severe Asthma in the German Asthma Net
17. Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort
18. Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease
19. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
20. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
21. Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis
22. German asthma net: Nasal polyposis in patients in the severe asthma registry
23. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis
24. Aktuelle Entwicklungen in der Schlafforschung und Schlafmedizin – eine Einschätzung der AG „Herz- und Kreislauferkrankungen“
25. The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control
26. YoungDGP-Pilotprojekt Pneumo Speed Dating – Innovatives Fortbildungsformat mit Zukunftspotenzial.
27. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells
28. As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort
29. Sarkoidose – Mechanismen und Bildgebung
30. Allergische bronchopulmonale Aspergillose (ABPA) – ein Update
31. Impact of interstitial lung disease on left ventricular myocardial function
32. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
33. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
34. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry
35. Phenotypes and treatment outcomes in idiopathic pulmonary arterial hypertension (IPAH) patients with comorbidities
36. Early-stage idiopathic pulmonary fibrosis is characterized by bronchoalveolar accumulation of SPP1+macrophages
37. Medikamentöse Therapie der pulmonalarteriellen Hypertonie mit Komorbiditäten – Welche Phänotypen gibt es, was gibt es zu beachten?
38. Pulmonale Hypertonie assoziiert mit Lungenerkrankungen
39. Diagnostik und Therapie der pulmonalarteriellen Hypertonie
40. No evidence to support the impact of migration background on treatment response rates and cancer survival: a retrospective matched-pair analysis in Germany
41. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients
42. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells.
43. Therapie der Sarkoidose. Ein Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP).
44. Phenotypes and treatment outcomes in idiopathic pulmonary arterial hypertension patients with comorbidities.
45. Bronchial Rheoplasty for Chronic Bronchitis: 6-Month Results from the European Registry Study
46. Initiation, response assessment and switch of antibody therapies in patients with severe asthma – a survey among German specialists
47. Response to biologics and clinical remission in the adult GAN severe asthma cohort.
48. German Asthma Net: Nasal polyposis in patients with severe asthma
49. Impact of smoking on biologicals treatment response in patients from the German Severe Asthma (GAN) Registry
50. Health Care Situation in the Treatment of Uncontrolled GINA Step 4/5 Patients in Germany
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.